Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
2,129,751
-
Share change
-
-36,581
-
Total reported value
-
$101,049,767
-
Price per share
-
$47.43
-
Number of holders
-
77
-
Value change
-
-$2,207,669
-
Number of buys
-
21
-
Number of sells
-
38
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q3 2021
As of 30 Sep 2021,
SPDR SERIES TRUST - S&P PHARMAC (XPH) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,129,751 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, BNP PARIBAS ARBITRAGE, SA, LPL Financial LLC, Hochman Cole Investment Advisors, Inc., ROYAL BANK OF CANADA, FIRST CITIZENS BANK & TRUST CO, WELLS FARGO & COMPANY/MN, and Private Advisor Group, LLC.
This page lists
77
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.